PATENT CLAIM ANALYSIS

Application Number: 15916595
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "497000"]

Abstract:
The present invention relates to generally to pharmaceutical formulations. Particularly, the present invention relates to a drug nanocarrier that is stabilized by lipids, preferably lecithins and/or lipid-terminated polyalkylene glycol, for the delivery of poorly soluble drugs with high drug loading and its utility in the fields of pharmaceutical formulation, drug delivery, medicine and diagnosis.

Claim (Index 8):
The method of  claim 1 , wherein the amphiphilic polymer is selected from the group consisting of phospholipid, poloxamer, poloxamine, TPGS, tween, ethoxylated hydrogenated castor oil, pegylated phospholipid, PLGA, PLA, PGA, and a combination thereof.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 90.0
- Lexical Diversity: 1.4186
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14765620', '15060663', '15798287', '12573591', '14490336']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7209162968071046
- 35 USC 102 Novelty (BERT): 0.4951413641717112
- Combined Prediction Score: 0.6983388035435653
- Mean Citation Score: 228.744078
- Max Citation Score: 239.43407
- Similarity Product: 174.73360059526263

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test